[ Editors Note: Starts & Stops is Medtech Insight’ s regular review of important medical device trial announcements as tracked by Informa’s MedDeviceTracker . Click here to request a demonstra
IN VITRO DIAGNOSTICS Financings Vermillion Inc. Vermillion Inc. grossed $5.6mm through the private sale of 3.75mm common shares at $1.40 (a 6% premium). Investors also received five-year warrants
The first two months of 2017 saw a flurry of alliances that involved Asian players, whose partnerships with western counterparts have noticeably risen in recent years. This is driven by companies in t
DexCom’s “Professional” CGM FDA approved DexCom Inc. ’s G4 Platinum Professional continuous glucose monitor, the firm announced June 3. The professional version of the monitor, which is already m